Or Yat Sun
SEC CIK 1571212 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | SVP, CSO, R, D | 373.0K | — | $697.1K | 22 | 2021-11-19 | 2026-02-12 |
Most active insiders at ENTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Luly Jay R. | Pres, CEO, Dir | — | $67.5K |
| 2 | Or Yat Sun | CSO | — | $34.0K |
| 3 | Kieffer Tara Lynn | Chief Product Strategy Off | — | $30.0K |
| 4 | Luu Brendan | Chief Business Off | — | $19.8K |
| 5 | Trout Harry R. III | See Remarks | — | $13.0K |
| 6 | Rottinghaus Scott T. | Chief Medical Off | — | $11.4K |
| 7 | Capps Kathleen S. | See Remarks | — | $7,486 |
| 8 | Kowalsky Matthew Paul | CLO | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-13 | 2026-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | CSO | A - Grant | $0.00 | +6,875 | 373.0K | +2% | $0 |
| 2026-02-13 | 2026-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | CSO | F - Tax | $14.25 | -3,413 | 374.9K | -0.9% | -$48.6K | |
| 2025-12-05 | 2025-12-05 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | CSO | S - Sale | $14.23 | -2,390 | 371.4K | -0.6% | -$34.0K | |
| 2025-12-03 | 2025-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | CSO | F - Tax | $14.12 | -753 | 373.8K | -0.2% | -$10.6K | |
| 2025-02-14 | 2025-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | CSO | F - Tax | $5.59 | -4,324 | 374.5K | -1% | -$24.2K | |
| 2025-02-14 | 2025-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | CSO | A - Grant | $0.00 | +9,750 | 378.9K | +3% | $0 | |
| 2024-12-10 | 2024-12-06 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | CSO | S - Sale | $8.06 | -2,591 | 369.1K | -0.7% | -$20.9K | |
| 2024-12-03 | 2024-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | CSO | F - Tax | $8.60 | -1,595 | 371.7K | -0.4% | -$13.7K | |
| 2024-02-14 | 2024-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | CSO | A - Grant | $0.00 | +3,680 | 374.4K | +1.0% | $0 | |
| 2024-02-14 | 2024-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | CSO | F - Tax | $12.41 | -1,080 | 373.3K | -0.3% | -$13.4K | |
| 2023-12-06 | 2023-12-05 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO, R, D | S - Sale | $9.63 | -2,412 | 370.7K | -0.6% | -$23.2K | |
| 2023-12-05 | 2023-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO, R, D | F - Tax | $9.49 | -1,595 | 373.1K | -0.4% | -$15.1K | |
| DM | 2023-03-17 | 2023-03-15 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO | S - Sale+OE | $44.45 | -13.9K | 388.4K | -3% | -$619.0K |
| D | 2023-03-17 | 2023-03-15 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO | M - OptEx | $14.00 | +13.9K | 388.6K | +4% | +$194.9K |
| M | 2023-02-15 | 2023-02-13 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO | A - Grant | $0.00 | +23.3K | 369.4K | +7% | $0 |
| 2023-02-15 | 2023-02-13 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO | F - Tax | $52.77 | -7,752 | 374.7K | -2% | -$409.1K | |
| 2022-12-05 | 2022-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO | F - Tax | $44.33 | -1,055 | 359.2K | -0.3% | -$46.8K | |
| D | 2022-11-28 | 2022-11-23 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO | A - Grant | $0.00 | +21.0K | 360.2K | +6% | $0 |
| M | 2022-02-15 | 2022-02-14 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO | A - Grant | $0.00 | +3,034 | 340.2K | +0.9% | $0 |
| 2022-02-15 | 2022-02-14 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO | F - Tax | $62.49 | -953 | 339.2K | -0.3% | -$59.6K | |
| 2021-12-03 | 2021-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO | F - Tax | $87.68 | -557 | 337.2K | -0.2% | -$48.8K | |
| D | 2021-11-23 | 2021-11-19 | ENTA | ENANTA PHARMACEUTICALS INC | Or Yat Sun | SVP, CSO | A - Grant | $0.00 | +6,800 | 337.7K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations